Personal Genome Screening for Healthy Adults
with Genomic Inform®


Your DNA provides important information that can influence your health at any stage in life. Use Genomic Inform®, a whole genome test that takes an in-depth look at thousands of your genes, to identify and understand the harmful changes in your DNA, if any. For most people, no harmful changes will be identified. But if they are, the results will enable you to:

Proactively address disease predisposition risk

Half of the annual deaths due to heart disease could be prevented. Early detection of cancer, before it’s had a chance to spread, can significantly improve survival rate. Plus there are many other disorders with a genetic component. The Genomic Inform® test identifies variants that increase your risk of developing these diseases.

Avoid passing a rare disease on to your children

An estimated 25 million or more people in the US suffer from a rare disease. Most are recessive, meaning that two copies of a harmful variant are required to develop the disease. Genomic Inform® screening can identify whether you and your partner are silent carriers of the same or similar rare disease variant, before passing it on to your child.


The direct-to-consumer tests advertised on TV, Facebook and other social media are very limited. They mostly provide recreational information. When they do provide health information, they most often test for only a few, well-characterized variants. Hundreds and even thousands of additional, equally harmful variants go untested. The result is an incomplete assessment of the health-related information in your DNA.

These popular direct-to-consumer tests look at only 0.01% of your DNA. Using whole genome sequencing (WGS), Genomic Inform® looks at more than 98% of your DNA.

The result is a significantly more complete analysis of your DNA. Including coverage of disease risk variants for conditions identified by the Centers for Disease Control and Prevention (CDC) as important genome screening applications:

  • Hereditary breast and ovarian cancer
  • Familial hypercholesterolemia (increased risk for heart disease)
  • Hereditary nonpolyposis colorectal cancer

As well as disease risk variants for conditions that lead to increased risk of venous thrombosis, myocardial infarction, inflammatory bowel disorders like ulcerative colitis and Crohn’s disease, polycystic kidney disease and many more.

Genomic Inform® also provides a more complete analysis for carrier variants. Including coverage of genetic disorders for which screening of all expectant mothers is recommended by both the American College of Medical Genetics and Genomics (ACMG) and the American College of Obstetrics and Gynecology (ACOG):

  • Cystic fibrosis
  • Thalassemia and related hemoglobinopathies
  • Fragile X syndrome
  • Spinal muscular atrophy

As well as many additional disorders with a high carrier frequency in individuals of Ashkenazi Jewish and other ethnic descents including Tay-Sachs disease, Canavan disease, Familial dysautonomia, Gaucher disease, Nieman-Pick disease, Usher syndrome, Bloom syndrome, Joubert disease and many more. Beyond providing a more complete analysis of disorders like these, Genomic Inform® additionally identifies carrier variants for disorders that are not considered by other tests including Rubenstein-Taybi syndrome, X-linked agammaglobulinemia, Simpson-Golabi-Behmel syndrome, Lesch-Nyan syndrome and many others.


Request information about the Genomic Inform® test online.

When any question have been answered, we’ll send you a saliva collection kit and test requisition form.

Fill out the test requisition form with your physician and return it with your saliva sample.

In ~8 weeks, your personalized report will be ready.

Please do not submit Protected Health Information (PHI) through this email address.

If you need to submit Protected Health Information (PHI), please call us at 617-209-2090 and we will work with you to submit the information through an alternate mechanism.

Otherwise, please continue: